Pharmaceutical lifecycle management making the most of each and every brand /
Furkejuvvon:
| Váldodahkki: | |
|---|---|
| Searvvušdahkki: | |
| Eará dahkkit: | |
| Materiálatiipa: | Elektrovnnalaš E-girji |
| Giella: | eaŋgalasgiella |
| Almmustuhtton: |
Hoboken, N.J. :
John Wiley & Sons,
c2012.
|
| Fáttát: | |
| Liŋkkat: | An electronic book accessible through the World Wide Web; click to view |
| Fáddágilkorat: |
Lasit fáddágilkoriid
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!
|
Sisdoallologahallan:
- pt. A. Lifecycle management business environment
- pt. B. Lifecycle management regulatory and legal environment
- pt. C. Patents and exclusivities
- pt. D. Developmental LCM
- pt. E. Commercial LCM
- pt. F. Biologics and biosimilars
- pt. G. The integrated brand LCM strategy and its implementation
- pt. H. Integrating LCM with portfolio management.